HutchMED (China) LIMITED (HMDCF) Operating margin 2016–2025
HutchMED (China) LIMITED (HMDCF) operating margin by fiscal year — reported operating income divided by reported revenue.
-7.1%FY2025 · since FY2016: -21.6% → -7.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7.1% | -0.2 pp |
| FY2024 | -6.9% | -9.1 pp |
| FY2023 | 2.2% | +97.8 pp |
| FY2022 | -95.6% | -3.4 pp |
| FY2021 | -92.2% | -5.9 pp |
| FY2020 | -86.3% | -14.8 pp |
| FY2019 | -71.4% | -28.2 pp |
| FY2018 | -43.3% | -21.1 pp |
| FY2017 | -22.1% | -0.5 pp |
| FY2016 | -21.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →